Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
AIDS Rev. 2023 Dec 13. doi: 10.24875/AIDSRev.M23000066. Online ahead of print.ABSTRACTViruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. Besides being used as treatment, antivirals have shown efficacy for preventing certain viral infections. Following the success in the HIV field, a renewed interest has emerged on the use of antivirals as prophylaxis for other viruses. The development of formulations with extended half-life has pushed further this consid...
Source: AIDS Reviews - December 13, 2023 Category: Infectious Diseases Authors: Vicente Soriano V íctor Moreno-Torres Carmen de Mendoza Jos é V Fernández-Montero Ana Trevi ño Octavio Corral Fernando de Jes ús Pablo Barreiro Source Type: research
